|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑 & i$ v2 m: s( s& u
i( n2 |6 l# M. e今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了
$ S( b$ @6 U" l5 Y$ ?2 w. U2 ?1 C; Q& N |$ {" n
头颈肿瘤BU入选ASCO 2025的研究3 ]* p+ Z0 @5 K) B( Y
Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.
3 p/ p9 P8 o; Q- A; n肿瘤内科-头颈肿瘤科姜愚团队: H; b$ b. r( N7 H6 p
1 z0 |" R8 T1 i. \
Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial., g# X6 H7 \9 g) h1 m6 t) h$ o* Y( m8 c
肿瘤内科-头颈肿瘤科刘磊团队$ V! J ~* m' M' p; H$ }9 G! c
0 \* J( E+ R, x' }A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.9 ?9 d% Q% s& ]1 r
肿瘤内科-头颈肿瘤科刘磊团队
; j& Z9 x8 b8 S2 r3 e# i
4 h! Y# t) o; C% q+ PA phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.9 Z- F9 l/ R3 P0 ^7 M! r
肿瘤内科-头颈肿瘤科刘磊团队3 `$ I8 p0 h* J! f1 Q4 p
& B. Z+ a/ i/ C
ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.2 @) E+ e" K! w' o. y$ p
肿瘤内科-头颈肿瘤科姜愚团队
6 M3 p3 b3 O" t- E' U& S |
|
[复制链接]
发表于 2025-5-2 09:58:22
" c+ p/ h6 V- L7 M, N